Phreesia, which provides a patient-intake software platform for healthcare providers, filed on Friday with the SEC to raise up to $125 million in an initial public offering.
The New York, NY-based company was founded in 2005 and booked $104 million in sales for the 12 months ended April 30, 2019. It plans to list on the NYSE under the symbol PHR. J.P. Morgan, Wells Fargo Securities, William Blair, Allen & Company and Piper Jaffray are the joint bookrunners on the deal. No pricing terms were disclosed.
